Research Article

HPTLC Analysis of Bioactivity Guided Anticancer Enriched Fraction of Hydroalcoholic Extract of Picrorhiza kurroa

Table 8

Comparative haematological profile of EAC, control, standard, and DCM fraction treated groups of Balb/C mice after ten days of treatment.

ParametersControl ± SDEAC control ± SD5-FU ± SDDPK ± SD

WBC 103/µL5.20 ± 0.269.50 ± 0.473.10 ± 0.150.55 ± 0.02
RBC 106/µL9.36 ± 0.467.29 ± 0.368.79 ± 0.448.42 ± 0.42
HGB g/dL13.40 ± 0.6710.70 ± 0.5313.00 ± 0.6511.30 ± 0.56
HCT %45.80 ± 2.2936.30 ± 1.8145.00 ± 2.2542.50 ± 2.12
MCV fL48.90 ± 2.4449.80 ± 2.4951.20 ± 2.5651.20 ± 2.56
MCH pg14.30 ± 0.7114.70 ± 0.7314.80 ± 0.7414.30 ± 0.71
MCHC g/dL29.30 ± 1.4629.30 ± 1.4628.90 ± 1.4429.20 ± 1.46
PLT 105/µL7.08 ± 0.3511.84 ± 0.596.83 ± 0.348.16 ± 0.41
RDW fL29.20 ± 1.4629.90 ± 1.4930.40 ± 1.5229.30 ± 1.46
PDW fL9.10 ± 0.4510.40 ± 0.529.00 ± 0.459.10 ± 0.45
MPV fL7.40 ± 0.377.90 ± 0.396.90 ± 0.347.50 ± 0.37
P-LCR %9.80 ± 0.4911.90 ± 0.596.10 ± 0.3010.20 ± 0.51

showed followed by Dunnett’s test in comparison to EAC control.